arrow
D

Damir Varešlija

Royal College of Surgeons in Ireland
H指数:20
被引数:1,387

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design, Synthesis, and Biological Evaluation of Novel Triazine-Based Dual Histone Deacetylase/phosphatidylinositol 3-kinase Inhibitors for Breast Cancer Therapy

基于三嗪的新型组蛋白去乙酰化酶/磷脂酰肌醇3-激酶双抑制剂的设计、合成及生物活性评价:用于乳腺癌治疗

2026-04-250
OAAI
Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer

靶向CDK12破坏雌激素受体染色质募集和ER-MED1转录在晚期ER+乳腺癌中的作用

2025-10-150
OAAI
PARP Inhibitors in the Neoadjuvant Setting; A Comprehensive Overview of the Rationale for their Use, Past and Ongoing Clinical Trials

PARP抑制剂在辅助治疗前设置中的应用;关于其使用合理性的全面概述及过去和正在进行的临床试验

2025-04-070
OA
RET overexpression leads to increased brain metastatic competency in luminal breast cancer
2024-06-101
OAAI
Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity

管腔型乳腺癌的身份取决于糖皮质激素受体活性的丧失

2023-10-305
OAAI
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism
2022-04-1149
OAAI
A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis

基于器官型培养的临床兼容药物筛选平台可确定预防和治疗脑转移的漏洞

2022-02-1716
OAAI
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities
2022-01-2650
OAAI
Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype
2021-01-0812
OAAI